mafenide has been researched along with Respiratory Distress Syndrome in 1 studies
Mafenide: A sulfonamide that inhibits the enzyme CARBONIC ANHYDRASE and is used as a topical anti-bacterial agent, especially in burn therapy.
Respiratory Distress Syndrome: A syndrome characterized by progressive life-threatening RESPIRATORY INSUFFICIENCY in the absence of known LUNG DISEASES, usually following a systemic insult such as surgery or major TRAUMA.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Munster, AM | 1 |
1 other study available for mafenide and Respiratory Distress Syndrome
| Article | Year |
|---|---|
The early management of thermal burns.
Topics: Administration, Topical; Airway Obstruction; Anti-Bacterial Agents; Anticoagulants; Bronchitis; Burn | 1980 |